Vivos (RDGL) Current Deferred Revenue (2010 - 2013)

Vivos' (RDGL) quarterly Current Deferred Revenue came in at $24241.0 in Q2 2013, down 96.88% year-on-year from $777482.0 in Q2 2012, and down 88.83% quarter-over-quarter from $217101.0 in Q1 2013.

Vivos (RDGL) Current Deferred Revenue (2010 - 2013) Analysis & Trends

Vivos has disclosed Current Deferred Revenue across 4 years of filings, most recently posting $24241.0 for Q2 2013.

  • Current Deferred Revenue for Q2 2013 came in at $24241.0, down 96.88% year-over-year; the trailing twelve-month figure through Jun 2013 was $24241.0 (down 96.88% YoY), and the FY2012 annual result was $265531.0, down 71.92% from the prior year.
  • Current Deferred Revenue came in at $24241.0 for Q2 2013 at Vivos, down from $217101.0 in the prior quarter.
  • In the past five years, Current Deferred Revenue ranged from a high of $1.2 million in Q4 2010 to a low of $24241.0 in Q2 2013.
  • The 4-year median for Current Deferred Revenue is $833940.5 (2012), against an average of $697042.2.
  • Across the five-year window, Current Deferred Revenue decreased 20.62% in 2011 and tumbled 96.88% in 2013, its largest moves.
  • Vivos' Current Deferred Revenue stood at $1.2 million in 2010, then slipped by 20.62% to $945765.0 in 2011, then slumped by 71.92% to $265531.0 in 2012, then plunged by 90.87% to $24241.0 in 2013.
  • The last three Current Deferred Revenue figures came in at $24241.0 (Q2 2013), $217101.0 (Q1 2013), and $265531.0 (Q4 2012), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn
10 Vivos - - -3,105.00

Historic Data

Download Data
DateValue
Jun 30, 2013 24,241.00
Mar 31, 2013 217,101.00
Dec 31, 2012 265,531.00
Sep 30, 2012 535,320.00
Jun 30, 2012 777,482.00
Mar 31, 2012 890,399.00
Dec 31, 2011 945,765.00
Sep 30, 2011 1.04 Mn
Jun 30, 2011 1.09 Mn
Dec 31, 2010 1.19 Mn